A city-wide program to encourage active and sustainable travel in young people
Not Applicable
- Conditions
- Active and sustainable travel in young peopleNot Applicable
- Registration Number
- ISRCTN17633761
- Lead Sponsor
- South Eastern Finland University of Applied Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Ongoing
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
1. 13 - 15-year-old young people who attend classes in the study schools
2. Give informed consent and have their guardian's consent to participate
3. Additionally, from amongst the participants, a sample of 12 to 15 young people with diverse travel habits and 2 to 4 parents will be recruited for the semi-structured interviews
Exclusion Criteria
Does not meet inclusion criteria
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Duration of moderate-to-vigorous physical activity (hours/day). Participants will use a validated Fibion® device (Fibion Inc., Jyväskylä, Finland) for 8 days, 24 hours a day at baseline, 4 months and 8 months. The Fibion® device is attached to the participant's right thigh with a waterproof cover and medical tape to measure sitting and various forms of physical activity, including cycling.
- Secondary Outcome Measures
Name Time Method 1. Active travel practices as a duration of different modes of transportation per week: walking, walking to the stop, cycling, cycling to the stop, personal motorized vehicle, bus, and car, assessed at baseline, 4 months and 8 months. Based on geographical information, the duration of trips is estimated using a map based PPGIS (Public Participatory GIS) survey, where participants indicate the mode of transportation, departure, and destination for each trip. In the PPGIS survey, participants are asked if they use the bus daily, several times a week, once or twice a week (weekly bus users), less than weekly, or never (less than weekly bus users)<br>2. Sitting time (accelerometer attached to thigh, Fibion device) assessed at baseline, 4 months and 8 months